Boston Scientific Corporation vs GE HealthCare Technologies Inc.
A head-to-head of Boston Scientific Corporation (BSX) and GE HealthCare Technologies Inc. (GEHC) across valuation, profitability, growth, and dividends. Green marks the more favourable value on that metric only — not a recommendation.
| Metric | BSX | GEHC |
|---|---|---|
| Market Cap | $70.88B | $28.22B |
| P/E (TTM) | 19.95 | 14.84 |
| Forward P/E | 14.88 | 11.18 |
| P/S | 4.04 | 1.32 |
| P/B | 3.20 | 2.61 |
| EV/EBITDA | 16.91 | 10.08 |
| Dividend Yield | — | 0.22% |
| Profit Margin | 17.29% | 9.10% |
| Gross Margin | 69.01% | 39.99% |
| Operating Margin | 19.78% | 13.39% |
| Revenue Growth (YoY) | +11.58% | +7.41% |
| FCF Yield | 3.96% | 5.49% |
| Debt / Equity | 41.78 | 92.99 |
| Current Ratio | 1.90 | 1.22 |
Share:
This comparison is for informational and educational purposes only, based on available data — not a recommendation to buy or sell any stock.